Field of the Invention
The present invention relates to medical devices, particularly to an electrosurgical balloon having one or more electrodes disposed on an exterior surface of the balloon, and a bipolar electrode configuration in which a pair of bipolar electrodes are disposed on an exterior surface of the balloon.
Background Art
Medicine is providing ever-increasing demands for devices that can navigate narrow passageways to a desired location within a body so that diagnostic and therapeutic procedures can be performed at that location. Currently, elongated medical devices such as catheters can extend into a body from outside via an access point through various connected passageways to a target location. It is sometimes desirable to perform electrosurgical procedures at the target location.
An electrosurgical procedure involves a medical device having an electrode tip that is electrically energized to perform a procedure such as coagulation, dissection, desiccation and cautery. The electrical energy can be provided in either direct current (DC) form or in alternating current (AC) form. Low frequency electrical energy, including DC, can stimulate muscle and nerves and have potentially undesirable outcomes, such as cardiac arrest, if not properly handled. Higher frequency electrical energy, and in particular electrical energy in the radiofrequency (RF) range (e.g., about 3 kilohertz to about 300 gigahertz), may not stimulate muscle or nerves, and therefore may be better suited to core and coagulate tissue. An electrode tip energized by ultrasonic energy can also be used to perform electrosurgical procedures such as coagulation and tissue ablation.
Modern day elongated medical devices can provide percutaneous access to inner organs and other tissue, and can allow clinicians to navigate to remote and narrow locations within a body. To provide such percutaneous access, these elongated medical devices must meet a variety of requirements such as a desired length, a sufficiently small outer diameter to permit navigation to narrow body passageways, and sufficiently large inner diameter to permit delivery of the required functionality to the remote location. In the case of an elongated medical device having an RF-powered electrode tip, for example, the device can have an inner diameter sufficiently large to transfer the required energy to the electrode tip. To guide the electrode tip to the target site within a body, the elongated medical device including the electrode tip can be deployed into the body through a small trocar. The elongated medical device is advanced in the body to the target site in the body, and the electrode tip is energized at the target site to perform the electrosurgical procedure. An elongated delivery system (e.g., a delivery catheter and/or guidewire) can be used to guide the elongated medical device through the body to the target site.
Electrode tips delivering RF energy can be monopolar or bipolar. A monopolar tip includes one electrode, and a ground pad electrode is located on the patient. Energy applied through the electrode travels through the patient to ground, typically the ground pad. With a bipolar tip, the ground pad electrode located on the patient is eliminated and replaced with a second electrode pole as part of the tip. These active and return electrodes of a bipolar tip are typically positioned close together to ensure that, upon application of electrical energy, current flows directly from the active to the return electrode. Bipolar tips can be advantageous compared to monopolar tips because the return current path only minimally flows through the patient. In bipolar tips, both the active and return electrode are typically exposed so they may both contact tissue, thereby providing a return current path from the active to the return electrode through the tissue. Also, the depth of tissue penetration may be advantageously less with a bipolar tip than with a monopolar tip. Whether monopolar or bipolar, electrode tips made of rigid materials govern the size and shape of the electrode tip that can be deployed through a small trocar and through narrow passageways in the body. The size and shape of the electrode tip can affect the functionality and performance capabilities of the electrode tip at a remote surgical site in the body.
What is needed is an electrode tip that can have a size and shape to achieve desired functionality and performance capabilities at a surgical site, with minimal or no size restrictions arising from the diameter of the elongated medical device, the trocar, and/or the delivery catheter. The present invention satisfies the above needs and provides further related advantages as will be made apparent by the description of the embodiments that follow.
Electrosurgical balloons and catheter assemblies employing electrosurgical balloons as electrode tips are presented. In some embodiments, an electrosurgical balloon includes an inflatable balloon body formed of a non-conductive substrate material, a pair of bipolar electrodes disposed on an exterior surface of the balloon body, and at least one fluid outlet hole in the balloon body. The fluid outlet hole can be configured to provide a conductive fluid from a fluid source to the pair of bipolar electrodes. The pair of bipolar electrodes include a first electrode and a second electrode in a bipolar electrode configuration.
In some embodiments, a catheter assembly includes a catheter and a balloon electrode tip. The catheter includes an elongated body having a distal end portion to which the balloon electrode tip is attached. The balloon electrode tip includes an inflatable balloon body formed of a non-conductive substrate material, a pair of bipolar electrodes disposed on an exterior surface of the balloon body, and at least one fluid outlet hole in the balloon body configured to provide a fluid from a fluid source to the pair of bipolar electrodes.
In some embodiments, a catheter assembly includes a first catheter, a second catheter, and a balloon electrode tip. The first catheter includes a first elongated body having a first distal end portion, and the second catheter includes a second elongated body having a second distal end portion and a lumen. The first catheter is disposed within the lumen. The balloon electrode tip is attached to the first distal end portion, and includes an outer inflatable balloon body formed of a non-conductive substrate material, an inner inflatable balloon body disposed inside the outer inflatable balloon body, and an electrode disposed on an exterior surface of the outer balloon body.
Methods of using a balloon electrode tip to treat tissue are also presented.
The accompanying drawings, which are incorporated herein and form a part of the specification, illustrate the present invention and, together with the description, further serve to explain the principles of the invention and to enable a person skilled in the pertinent art to make and use the invention. In the drawings, like reference numbers, letters, or renderings indicate identical or functionally similar elements.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present application including the definitions will control. Also, unless otherwise required by context, singular terms shall include pluralities and plural terms shall include the singular. All publications, patents and other references mentioned herein are incorporated by reference in their entireties for all purposes.
The term “invention” or “present invention” as used herein is a non-limiting term and is not intended to refer to any single embodiment of the particular invention but encompasses all possible embodiments as described in the application.
According to some embodiments of the present invention, an electrosurgical balloon includes one or more electrodes integrated onto the exterior surface of an expandable balloon (i.e., a balloon that can be expanded by inflation with a gas or liquid). The balloon can formed of a non-conductive substrate material. The electrosurgical balloon can be incorporated into a catheter assembly. The balloon can be disposed at a distal end of an elongated medical device (e.g., a catheter) to provide the catheter with electrosurgical functionality. Catheter lead wire(s) that can be connected to a power source at a proximal end of the catheter are carried by the catheter to the catheter's distal end to connect with the electrode(s).
The one or more electrodes can be formed of any suitable material. For example, the electrode(s) can be a biocompatible conductive wire (such as stainless steel or titanium) adhered to the exterior surface of the balloon, or the electrode(s) can be formed of a conductive ink applied (e.g., by a printing or stamping process) to the surface of the balloon substrate material. The wire or conductive ink electrode(s) on the balloon's surface can include an exposed electrode portion (for tissue treatment at a surgical site) and a lead portion (formed of wire or conductive ink). The electrode lead portion can be soldered to a distal end portion of the catheter lead wire(s). The solder connections and the electrode lead portion can be insulated (e.g., using an insulative material (such as ink or paint that is nonconductive) deposited over a conductive ink electrode, or using an insulative sheath on a wire electrode). The conductive ink for forming an electrode can include ink or paint formed of conductive materials such as, for example, metallic particles (e.g., powdered or flaked silver), carbon, conductive polymers or similar materials. The conductive ink can also include a compliant material that allows dry conductive ink on the balloon to spread with balloon expansion, thereby maintaining the conductive pathway from the catheter lead wire to the electrode lead portion to the exposed electrode portion.
The proximal end of the balloon can be mounted to a rigid ring which is fed into the distal end of the catheter, and the rigid ring can be the site for soldering of the electrode lead portion with the catheter lead wire. The balloon can be made of compliant material (e.g., silicone, latex) or non-compliant material (e.g., PVC, PE, PET). The balloon material can be porous or non-porous with respect to the fluid used for inflation (e.g., saline). The balloon can have a double diameter (with a smaller diameter proximal end and a larger diameter distal end) for stability and to facilitate mounting to the catheter. The balloon can be any configuration or shape (e.g., tubular, spherical) and can be various sizes, allowing the balloon to be designed for a myriad of therapies. The size and shape of the balloon when inflated a given inflation amount can be tailored based on the anatomical site(s) where the balloon is intended to be deployed for an electrosurgical operation, as well as the size of the patient (e.g., sized for adult anatomies (i.e., a comparatively large balloon size) or sized for infant anatomies (i.e., a comparatively small balloon size)).
The electrosurgical balloon can be provided with a monopolar (single) electrode system or a bipolar (double) electrode system. The electrode(s) can be configured to provide an appropriate wattage for the treatment. For example, for bipolar RF treatments in some embodiments, the bipolar electrodes of the electrosurgical balloon can be supplied with RF energy in a range of from about 2 to about 60, from about 10 to about 50, from about 15 to about 45, or from about 10 to about 30 watts. In some embodiments, an electrosurgical procedure is conducted with the bipolar electrodes of the electrosurgical balloon using about 18 watts of RF energy. The level of electrical power used in conjunction with a bipolar system (as well as monopolar system) can be varied and optimized for a particular application, and, if sufficiently high, can generate heat sufficient to dissect, coagulate, or otherwise heat-treat the tissue to which it is applied. This can render the tissue suitable for a variety of surgical procedures, such as, for example, blunt dissection. Exemplary tissue treatment procedures that can employ the balloon electrodes described herein include, for example, dissection and coagulation as mentioned above, as well as blunt dissection with coagulation, spot coagulation, and coagulation of large tissue planes.
The inflation amount of a balloon is adjustable, thereby allowing individualized size adjustments at the surgical site of a particular patient. The inflation amount (measured by the internal pressure (e.g., psi) in the balloon) can be varied to improve the conformability of the balloon to tissue surfaces, even on irregular tissue surfaces. Greater conformability of the balloon to the tissue surface can increase the electrode area in contact with tissue, which may result in reduced treatment times and/or reduced power requirements. Non-compliant balloons can assure a distance between electrodes, and ensure the inflated balloon size and shape is substantially maintained to a predetermined configuration. The inflation amount can also be used to adjust the gap between bipolar electrodes if the balloon is compliant. For RF treatments, variation in the gap between bipolar electrodes can vary the RF application to the tissue. For example, the closer the bipolar electrodes are to each other the more focused the RF energy that is applied to the area between the electrodes, permitting deeper penetration of the RF energy into the tissue in that area. In some embodiments, one or more of the electrode(s) on the balloon surface are configured to deliver ultrasonic therapies. In some embodiments, the electrosurgical balloon is configured to provide both. RF applications and ultrasonic applications.
In some embodiments, a bipolar electrode pair is provided on the exterior surface of the balloon. The electrode pair includes a first electrode (e.g., active electrode) serving as a first pole of a bipolar electrode configuration and a second electrode (e.g., return electrode) serving as a second pole of the bipolar electrode configuration. The electrodes are separated from each other on the balloon's exterior surface, and are insulated from each other by the separation area formed by the non-conductive balloon substrate material. Weeping holes are provided in the balloon substrate material. After delivery to the treatment site in its deflated state, the balloon can be inflated with a fluid. A portion of the fluid can exit through the weeping holes. The weeping holes are specifically positioned in the balloon so as to ensure that fluid exiting the balloon is provided to the pair of electrodes so as to fluidly connect the electrodes together. In some embodiments, the fluid used to inflate the balloon is a conductive fluid (e.g., saline). The weeping holes in the balloon allow the conductive fluid to flow (“weep”) to the pair of electrodes. The wept conductive fluid produces an electric coupling to the treatment site by providing a conductive pathway for energy to flow between the pair of electrodes at the treatment site. Moreover, the weeping of fluid can mitigate any thermal expansion of the balloon arising from heat dissipating from the energized electrodes.
The weeping holes can be configured to open to release the conductive fluid only once the balloon has been expanded to a given inflation amount. For example, a complaint (e.g., silicone) balloon can be formed by dipping a mandrel in silicon and curing the silicon, as known to one of skill in the art. The mandrel can be configured to form a balloon having areas of differing thickness. For example, the mandrel can be provided with dimples (or alternatively, bumps), which form corresponding bumps (or alternatively, corresponding dimples) in the balloon that have a greater thickness than the remainder of the balloon. These bumps (or dimples) in the balloon serve as the sites for pin holes, which can be formed in the bumps (or dimples) of the balloon in the deflated configuration. The thickness of the bump (or dimple) to the size of the pin hole is such that the hole is effectively too small for release of the conductive fluid when the balloon is deflated, but opens to form the weeping hole once the balloon is inflated. Alternatively, the balloon can be provided with a uniform thickness (without dimples/bumps) so that the pin holes can be provided anywhere in the balloon. The balloon thickness to the size of the pin hole is such that the pin holes are too small for release of the conductive fluid when the balloon is deflated, but opens to form the weeping holes once the balloon is inflated. Alternatively or in addition to the weeping holes that are configured to open only upon balloon inflation, the balloon may be provided with weeping holes configured to be always open regardless of the state of inflation of the balloon.
In some embodiments, in addition to weeping holes, drug delivery holes can be provided in the balloon for delivery of drugs from a drug source to the treatment site. Thus, both electrosurgical and pharmaceutical-based therapies can be applied to the treatment site using the electrosurgical balloon.
In some embodiments, the electrosurgical balloon can include two balloons: an outer balloon and an inner balloon (see, e.g., catheter assembly 200 described below with references to
In some embodiments, the outer balloon is made of a compliant material, and the inner balloon is made of a non-compliant material. In some embodiments, the outer balloon is made of a non-compliant material, and the inner balloon is made of a compliant material. In some embodiments, both the inner and outer balloons are made of a compliant material, and in other embodiments, both the inner and outer balloons are made of a non-compliant material. The fluid can be a gas (e.g., air) or a liquid (e.g., saline). In some embodiments, the outer balloon is configured to be inflated with a liquid, and the inner balloon is configured to be inflated with a gas. In some embodiments, the outer balloon is provided with a pair of electrodes having a bipolar electrode configuration. In such embodiments, the outer balloon can be selectively inflated with fluid from a fluid source and has weeping holes for dispensing the fluid to the pair of electrodes as earlier described. The inner balloon can be used for support and keeping the electrodes on the outer balloon in place during tissue treatment, while the outer balloon can be controlled to vary the inflation amount and pressure so as to control the amount of fluid that weeps, the surface area contact, and the distance between bipolar electrodes.
In some embodiments, the catheter can be slidably disposed within a lumen of an outer catheter. In some embodiments, the catheter can be fully retracted within the outer catheter so that the deflated balloon can reside in the lumen of the outer catheter until deployed at the treatment site. In some embodiments, the balloon is attached to both the distal end of the inner catheter and the distal end of the outer catheter. When the balloon is inflated, movement of the inner catheter relative to the outer catheter can force the balloon out of or into the lumen of the outer catheter, and the application of such force can change the shape and internal pressure of the balloon. This relative movement of the catheters can be used to control the balloon area in contact with the tissue. The movement can be used to control the amount of fluid that weeps and, for bipolar embodiments, the distance between bipolar electrodes.
In some embodiments, the catheter assembly constituted by the catheter and the electrosurgical balloon (serving as the balloon electrode tip) in its deflated configuration can extend through the lumen of a 2-French or larger catheter. In operation, the catheter assembly (including the inner catheter, the outer catheter if provided, and the electrosurgical balloon) can be delivered through a trocar to a percutaneous treatment site using a delivery system. As an example only and not by way of limitation, a delivery catheter is inserted through the trocar to a specific treatment site. A guidewire is inserted through the delivery catheter to the treatment site. The delivery catheter is removed, and the catheter assembly is advanced along the guidewire to the site. The electrosurgical balloon is extended from the outer catheter (if provided) at the site and inflated. The electrode(s) on the balloon's exterior surface are energized and targeted tissue is contacted with the energized balloon electrode tip. After the electrosurgical procedure is conducted, the guidewire and the catheter assembly are be removed either simultaneously or sequentially in any order.
The electrosurgical balloon according to embodiments presented herein allows increased surface area to be in contact with the targeted tissue beyond the standard 5 mm trocar diameter of typical laparoscopic instruments. Thus, a catheter assembly including the electrosurgical balloon allows delivery of a large electrode system through a small trocar. The electrosurgical balloon can allow electrosurgical procedures to be conducted using an electrode system that has a size and shape to achieve desired functionality and performance capabilities at the surgical site, with minimal or no size restrictions arising from the diameter of the catheter assembly, the trocar, and/or the delivery catheter.
Embodiments of the electrosurgical balloon described herein can be used for many procedures, including percutaneous treatment of aneurysms, treatment of mitral valve regurgitation by tightening the annulus around the mitral valve, treatments in the upper and lower gastrointestinal tract (GI) (including, e.g., bleeding varices, ulcers, caustic poisons, Crohn's disease), diverticulosis, varicose veins, sympathetic nerves (e.g., renal denervation by RF ablation), tumors, gene and stem cell therapies, and other surgical procedures in which treatment can include vessel sealing/coagulation, tissue shrinkage, and/or tissue ablation.
To further illustrate electrosurgical balloons and catheter assemblies disclosed herein, exemplary embodiments will now be described with reference to the Figures. It should be understood that any features of an embodiment disclosed herein can be combined with any features of any other embodiment disclosed herein, without departing from the scope of the present disclosure. Thus, any of the features of the electrosurgical balloons and catheter assemblies described above can be combined with any features of the exemplary embodiments described below with reference to the Figures.
Outer catheter 110 has an elongated body 112 with a lumen 116. Lumen 116 can extend from a proximal end portion (not shown) to a distal end portion 114. Inner catheter 130 is disposed within lumen 116 of outer catheter 110. Inner catheter 130 has an elongated body 132 and a distal end portion 134. In some embodiments, balloon electrode tip 120 is attached to distal end portion 134 of inner catheter 130. In some embodiments, balloon electrode tip 120 is also attached to distal end portion 114 of outer catheter 110.
In embodiments where balloon body 122 is attached to outer catheter 110, fluid can be supplied into balloon body 122 via a fluid supply lumen in outer catheter 110. Fluid supply from outer catheter 110 (not shown) can be an alternative to or in addition to dispensing fluid from inner catheter 130 via openings 136. For example, outer catheter 110 can include a lumen that communicates with the interior chamber of balloon body 122 for filling balloon body 122 with fluid supplied from the lumen.
Balloon body 122 is provided with a plurality of weeping holes 126 which expel a portion of the fluid inflating balloon body 122. In some embodiments as described above, weeping holes 126 can be configured as valves that remain closed when balloon body 122 is deflated but which are opened when balloon body 122 is inflated to a given minimum inflation amount and/or internal pressure.
Electrodes 156a and 156b can be placed anywhere on exterior surface 124 of balloon body 122. In the embodiments shown in
In the embodiment shown in
In some embodiments, a rigid ring 140 can be mounted on the exterior of a cylindrical portion 166a (see
A distal portion of balloon body 120 can be attached to distal end portion 134 of inner catheter 130. As shown in
At a proximal end 129a of balloon body 122 (extending proximally from cylindrical portion 166a) is a cylindrical portion which forms a throat 123 of balloon body 122. Throat 123 has a proximal opening 123a for receiving inner catheter 130 into the interior chamber of balloon body 122. Throat 123 can have a diameter corresponding to either the outer diameter of inner catheter 130. Inner catheter 130 and throat 123 can have a fluid-tight sealing engagement, thereby permitting fluid dispensed from outlet openings 136 to fill the interior chamber of balloon body 122 and inflate balloon body 122.
When balloon body 122 is inflated, cylindrical portion 162a of distal portion 162 can abut against the distal end of outer catheter 110 as shown in
In some embodiments, as shown in
In any of the embodiments described herein, inner catheter 130 can be slidably disposed within lumen 116 of outer catheter 110. In the embodiment of
The inflation amount and internal pressure of balloon body 122 can be varied to control the fluid flow rate of fluid from weeping holes 126 and to assist in achieving desired electrode contact on tissue surfaces. Moreover, the inflation amount and internal pressure of balloon body 122 can be varied to control the distance between bipolar electrodes 156a and 156b if the balloon body is made of compliant material. The inflation amount and internal pressure can be controlled by adjusting the amount of fluid dispensed into the internal chamber of balloon body 122 (via outlet openings 136) (i.e., the inflation amount) and/or by manipulating the position of distal end portion 134 of inner catheter 130 relative to distal end portion 114 of outer catheter 110. Adjustment of the inflation amount can be independent of or in conjunction with the manipulation of the relative position of the distal end portions of the inner and outer catheters.
As an illustration, in the embodiments of
Weeping holes 126 can be configured to close when the balloon body is deflated and open when the balloon body 122 is inflated to a given minimum inflation amount and/or internal pressure. Increasing the inflation amount and/or internal pressure (beyond the minimum which opens holes 126) can increase the flow rate of fluid from holes 126, which may be desired to control the temperature at the treatment site. The flow rate of the electrically conductive fluid can affect the thermal characteristics of the tissue. For RF applications for example, when the fluid is electrically conductive fluid, the fluid can act as a heat sink, absorbing and carrying away excess or undesirable thermal energy resulting from electrically energizing electrodes 156a and 156b. The electrically conductive fluid can also provide electrical dispersion by distributing the applied current over a larger surface area, thereby limiting the potential for undesirable thermal concentration. An uncontrolled or abundant flow rate can provide too much electrical dispersion and cooling at the electrode/tissue interface. On the other hand, a flow rate that is too low could lead to excessive heat and arcing.
Moreover, the electrically conductive fluid can be used to help maintain temperatures within ranges conducive to coagulation of tissue (e.g., temperatures hot enough to denature the collagen and most soft tissue and bone, however not so hot that tissue is damaged to such an extent that it cannot be easily absorbed back into the body during a healing process) as opposed to charred, desiccated tissue. Collagen shrinkage, which causes coagulation, is a function of time and temperature. At 100° C., coagulation occurs substantially instantaneously, and at higher temperatures there will also be coagulation. Coagulation can begin at temperatures lower than 100° C., but the coagulation may occur more gradually. Without fluid (e.g., saline) present at the tissue being treated, temperatures can quickly rise above 100° C., and at such higher temperatures there is a greater likelihood of tissue sticking and charring. As one of skill in the art would appreciate, the time and temperature applied can be varied to suit a particular use. An RF power system can be controlled by suitable software to obtain desired power delivery characteristics. For example, in some embodiments, a control device or custom generator can be configured to allow the user to select a “pulse” mode of the RF power whereby the RF power to the balloon electrode tip is repeatedly turned on and off. Pulsed RF power may help effectively treat thick tissues as would be would be recognized by one of skill in the art. Moreover, in some embodiments, fluid flow rates from weeping holes 126 can be controlled based on the applied RF power to maintain temperatures at the treatment site within a desired range.
In embodiments described herein, saline has been provided as the exemplary electrically conductive fluid for filling balloon body 122 and expelling through weeping holes 126; however other electrically conductive fluids may be used alternatively or additionally, consistent with the embodiments presented herein. The fluid for filling balloon body 122 and expelling through weeping holes 126 may also comprise an electrically non-conductive fluid (e.g., deionized water and lactated ringers). The use of a non-conductive fluid still provides certain advantages over the use of a dry electrode including, for example, reduced occurrence of tissue sticking to the electrodes of the tip assemblies disclosed herein, and cooling of the electrodes and/or tissue.
In some embodiments, balloon electrode tip 120 (or 120′) is provided with an inner balloon body (disposed inside the interior chamber of balloon body 122). An inner balloon body can provide balloon electrode tip 120 with a double-wall construction that is more resistant to displacement. The inner balloon body can serve as a support for electrode tip 120 to enhance the stability of balloon body 122 and help ensure that the exposed electrode portions of electrodes 156a and 156b on distal portion 162 can be steadily placed in contact with target tissue. The outer balloon body 122 can be adjustably inflated with fluid to vary its shape or internal pressure to control fluid flow rate from weeping holes 126, vary the distance between electrodes and/or achieve desired electrode contact on tissue surfaces. In some embodiments, the inner balloon body can always be filled with fluid once deployed (without adjustment).
An exemplary embodiment of a catheter assembly 200 having a double-wall construction formed by inner and outer balloons will now be described with reference to
Catheter assembly 200 includes a double-walled balloon electrode tip 220 having an outer balloon body 222 and an inner balloon body 272. Outer balloon body 222 has an exterior surface 224 (on which one or more electrodes are disposed, not shown) and an interior chamber 222a within which is disposed inner balloon body 272. Inner balloon body 272 has an interior chamber 272a. The distal end of inner balloon body 272 is attached to distal end portion 134 of inner catheter 130 at an attachment portion 278a. The proximal end of inner balloon body 272 has a throat 273 with a proximal opening 273a for receiving distal end portion 134 of inner catheter 130 into interior chamber 272a. Throat 273 can have a diameter corresponding to the outer diameter of inner catheter 130. Inner catheter 130 and throat 273 can have a fluid-tight sealing engagement at attachment portion 278b (see
A ring (such as ring 140) can be used to attach outer balloon body 222 to outer catheter 110, and a ring (such as ring 140′) can be used to attach throat 273 of inner balloon catheter 272 to inner catheter 130. The attachment configurations illustrated in the embodiment of
Electrode(s), weeping holes and fluid outlets in the balloon bodies and catheters have been omitted from illustration in the views of
The foregoing description of the specific embodiments of the devices and methods described with reference to the Figures will so fully reveal the general nature of the invention that others can, by applying knowledge within the skill of the art, readily modify and/or adapt for various applications such specific embodiments, without undue experimentation, without departing from the general concept of the present invention. For example, as earlier noted, the balloon electrode can have a balloon body of any configuration or shape (e.g., tubular, spherical, etc.) and can be various sizes, allowing the balloon to be designed for a myriad of therapies.
Also, in any of the embodiments disclosed herein, a biocompatible conductive wire can used for the one or more balloon electrodes in place of a conductive ink electrode, and vice versa. Thus, conductive ink electrodes 156a and 156b can be replaced with wire electrodes. In some embodiments, the exposed electrode portions of electrodes 156a and 156b can be formed of conductive ink, and their lead portions 158a and 158b can be formed of wire leads. In embodiments using wire electrodes on the exterior surface of the balloon body, the wire electrode should be configured to extend with balloon expansion. An exemplary configuration of a wire electrode 156′ having a wire lead portion 158′ is illustrated in
Also, in any of the embodiments disclosed herein, the one or more balloon electrodes can be placed anywhere on the exterior surface of the balloon body. As described above with reference to
In any of these embodiments of the exemplary balloon electrode tips 120a-e illustrated in
Also, for example, in some embodiments the bipolar balloon electrode tips described herein can be used as a selectably monopolar tip, switchable between a bipolar mode and a monopolar mode. In the monopolar mode, at least one of the electrodes 156a and 156b is connected to a power generator so as to deliver energy as a monopolar (active) electrode, and there is no return electrode on the device (rather, a ground pad on the patient may be used as known in the art). A monopolar electrode system can be particularly suitable for ablating tissue. In some embodiments, the monopolar electrode may be supplied with RF energy (including pulsed RF energy), ultrasonic energy, or any other suitable energy for ablating tissue.
Therefore, it should be apparent that adaptations and modifications are intended to be within the meaning and range of equivalents of the disclosed embodiments, based on the teaching and guidance presented herein. It is to be understood that the phraseology or terminology herein is for the purpose of description and not of limitation, such that the terminology or phraseology of the present specification is to be interpreted by the skilled artisan in light of the teachings and guidance. The breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
2888928 | Seiger | Jun 1959 | A |
3682130 | Jeffers | Aug 1972 | A |
3750650 | Ruttgers | Aug 1973 | A |
4060088 | Morrison, Jr. et al. | Nov 1977 | A |
4195637 | Gruntzig et al. | Apr 1980 | A |
4207897 | Lloyd et al. | Jun 1980 | A |
4244371 | Farin | Jan 1981 | A |
4248224 | Jones | Feb 1981 | A |
4275734 | Mitchiner | Jun 1981 | A |
4276874 | Wolvek et al. | Jul 1981 | A |
4278090 | van Gerven | Jul 1981 | A |
4321931 | Hon | Mar 1982 | A |
4342218 | Fox | Aug 1982 | A |
4355642 | Alferness | Oct 1982 | A |
4377168 | Rzasa et al. | Mar 1983 | A |
4381007 | Doss | Apr 1983 | A |
4519389 | Gudkin et al. | May 1985 | A |
4598698 | Siegmund | Jul 1986 | A |
4601290 | Effron et al. | Jul 1986 | A |
4664110 | Schanzlin | May 1987 | A |
4671274 | Scrochenko | Jun 1987 | A |
4736749 | Lundback | Apr 1988 | A |
4779611 | Grooters et al. | Oct 1988 | A |
4802475 | Weshahy | Feb 1989 | A |
4919129 | Weber et al. | Apr 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4932952 | Wojciechowicz, Jr. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4985030 | Melzer et al. | Jan 1991 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5047028 | Qian | Sep 1991 | A |
5190541 | Abele et al. | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5234428 | Kaufman | Aug 1993 | A |
5254117 | Rigby et al. | Oct 1993 | A |
5281215 | Midler | Jan 1994 | A |
5309896 | Moll et al. | May 1994 | A |
5316000 | Chapelon et al. | May 1994 | A |
5317878 | Bradshaw et al. | Jun 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5322520 | Milder | Jun 1994 | A |
5323781 | Ideker et al. | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324284 | Imran | Jun 1994 | A |
5324286 | Fowle | Jun 1994 | A |
5330521 | Cohen | Jul 1994 | A |
5334181 | Rubinsky et al. | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336220 | Ryan et al. | Aug 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5353783 | Nakao et al. | Oct 1994 | A |
5354258 | Dory | Oct 1994 | A |
5361752 | Moll et al. | Nov 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5385148 | Lesh et al. | Jan 1995 | A |
5395312 | Desai | Mar 1995 | A |
5396887 | Imran | Mar 1995 | A |
5397304 | Truckai | Mar 1995 | A |
5400770 | Nakao et al. | Mar 1995 | A |
5400783 | Pomeranz et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403309 | Coleman et al. | Apr 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405376 | Mulier et al. | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5417709 | Slater | May 1995 | A |
5423807 | Milder | Jun 1995 | A |
5423811 | Imran et al. | Jun 1995 | A |
5427119 | Swartz et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431649 | Mulier et al. | Jul 1995 | A |
5433708 | Nichols et al. | Jul 1995 | A |
5435308 | Gallup et al. | Jul 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5441503 | Considine et al. | Aug 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5443470 | Stern et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5450843 | Moll et al. | Sep 1995 | A |
5452582 | Longsworth | Sep 1995 | A |
5452733 | Sterman et al. | Sep 1995 | A |
5460629 | Shlain et al. | Oct 1995 | A |
5462545 | Wang et al. | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5469853 | Law et al. | Nov 1995 | A |
5472876 | Fahy | Dec 1995 | A |
5478309 | Sweezer et al. | Dec 1995 | A |
5478330 | Imran et al. | Dec 1995 | A |
5486193 | Bourne et al. | Jan 1996 | A |
5487385 | Avitall | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5490819 | Nicholas et al. | Feb 1996 | A |
5496271 | Burton et al. | Mar 1996 | A |
5496312 | Klicek | Mar 1996 | A |
5497774 | Swartz et al. | Mar 1996 | A |
5498248 | Milder | Mar 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5505700 | Leone | Apr 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5516505 | McDow | May 1996 | A |
5520682 | Baust et al. | May 1996 | A |
5522870 | Ben-Zion | Jun 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540562 | Giter | Jul 1996 | A |
5540679 | Fram et al. | Jul 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5542945 | Fritzsch | Aug 1996 | A |
5545195 | Lennox et al. | Aug 1996 | A |
5545200 | West et al. | Aug 1996 | A |
5549661 | Kordis et al. | Aug 1996 | A |
5555883 | Avitall | Sep 1996 | A |
5556397 | Long et al. | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5560362 | Silwa, Jr. et al. | Oct 1996 | A |
5562702 | Huitema et al. | Oct 1996 | A |
5562720 | Stern et al. | Oct 1996 | A |
5569241 | Edwards | Oct 1996 | A |
5569243 | Kortenbach et al. | Oct 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573532 | Chang et al. | Nov 1996 | A |
5575766 | Swartz et al. | Nov 1996 | A |
5575788 | Baker et al. | Nov 1996 | A |
5575810 | Swanson et al. | Nov 1996 | A |
5578007 | Imran | Nov 1996 | A |
5582609 | Swanson et al. | Dec 1996 | A |
5588432 | Crowley | Dec 1996 | A |
5590657 | Cain et al. | Jan 1997 | A |
5595183 | Swanson et al. | Jan 1997 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5605539 | Buelna et al. | Feb 1997 | A |
5607422 | Smeets et al. | Mar 1997 | A |
5607462 | Imran | Mar 1997 | A |
5617854 | Munsif | Apr 1997 | A |
5630837 | Crowley | May 1997 | A |
5637090 | McGee et al. | Jun 1997 | A |
5643197 | Brucker et al. | Jul 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5656029 | Imran et al. | Aug 1997 | A |
5658278 | Imran et al. | Aug 1997 | A |
5671747 | Connor | Sep 1997 | A |
5673695 | McGee et al. | Oct 1997 | A |
5676662 | Fleischhacker et al. | Oct 1997 | A |
5676692 | Sanghvi et al. | Oct 1997 | A |
5676693 | Lafontaine | Oct 1997 | A |
5678550 | Bassen et al. | Oct 1997 | A |
5680860 | Imran | Oct 1997 | A |
5681278 | Igo et al. | Oct 1997 | A |
5681294 | Osborne et al. | Oct 1997 | A |
5681308 | Edwards et al. | Oct 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5687737 | Branham et al. | Nov 1997 | A |
5688267 | Panescu et al. | Nov 1997 | A |
5690611 | Swartz et al. | Nov 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697925 | Taylor | Dec 1997 | A |
5697927 | Imran et al. | Dec 1997 | A |
5697928 | Walcott et al. | Dec 1997 | A |
5713942 | Stern | Feb 1998 | A |
5716389 | Walinsky et al. | Feb 1998 | A |
5718241 | Ben-Haim et al. | Feb 1998 | A |
5718701 | Shai et al. | Feb 1998 | A |
5720775 | Larnard | Feb 1998 | A |
5722402 | Swanson et al. | Mar 1998 | A |
5730074 | Peter | Mar 1998 | A |
5730127 | Avitall | Mar 1998 | A |
5730704 | Avitall | Mar 1998 | A |
5733280 | Avitall | Mar 1998 | A |
5735280 | Sherman et al. | Apr 1998 | A |
5735290 | Sterman et al. | Apr 1998 | A |
5743903 | Stern et al. | Apr 1998 | A |
5746224 | Edwards | May 1998 | A |
5755760 | Maguire et al. | May 1998 | A |
5766167 | Eggers et al. | Jun 1998 | A |
5769846 | Edwards et al. | Jun 1998 | A |
5782828 | Chen et al. | Jul 1998 | A |
5785706 | Bednarek | Jul 1998 | A |
5788636 | Curley | Aug 1998 | A |
5792140 | Tu et al. | Aug 1998 | A |
5797905 | Fleischman et al. | Aug 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5800428 | Nelson et al. | Sep 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5827216 | Igo et al. | Oct 1998 | A |
5836947 | Fleischman et al. | Nov 1998 | A |
5840030 | Ferek-Petric et al. | Nov 1998 | A |
5843021 | Edwards et al. | Dec 1998 | A |
5843152 | Tu et al. | Dec 1998 | A |
5844349 | Oakley et al. | Dec 1998 | A |
5846187 | Wells et al. | Dec 1998 | A |
5846191 | Wells et al. | Dec 1998 | A |
5849028 | Chen | Dec 1998 | A |
5861021 | Thome et al. | Jan 1999 | A |
5871523 | Fleischman et al. | Feb 1999 | A |
5871525 | Edwards et al. | Feb 1999 | A |
5873845 | Cline et al. | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5876399 | Chia et al. | Mar 1999 | A |
5879295 | Li et al. | Mar 1999 | A |
5879296 | Ockuly et al. | Mar 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5881732 | Sung et al. | Mar 1999 | A |
5882346 | Pomeranz et al. | Mar 1999 | A |
5885278 | Fleischman | Mar 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5895355 | Schaer | Apr 1999 | A |
5895417 | Pomeranz et al. | Apr 1999 | A |
5897553 | Mulier et al. | Apr 1999 | A |
5897554 | Chia et al. | Apr 1999 | A |
5899898 | Arless et al. | May 1999 | A |
5899899 | Arless et al. | May 1999 | A |
5902289 | Swartz et al. | May 1999 | A |
5904711 | Flom et al. | May 1999 | A |
5906580 | Kline-Schoder et al. | May 1999 | A |
5906587 | Zimmon | May 1999 | A |
5906606 | Chee et al. | May 1999 | A |
5908029 | Knudson et al. | Jun 1999 | A |
5913854 | Maguire et al. | Jun 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5916214 | Cosio et al. | Jun 1999 | A |
5921924 | Avitall | Jul 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5925045 | Reimels et al. | Jul 1999 | A |
5927284 | Borst et al. | Jul 1999 | A |
5928191 | Houser et al. | Jul 1999 | A |
5931810 | Grabek | Aug 1999 | A |
5931848 | Saadat | Aug 1999 | A |
5935123 | Edwards et al. | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5954661 | Greenspon et al. | Sep 1999 | A |
5957919 | Laufer | Sep 1999 | A |
5971980 | Sherman | Oct 1999 | A |
5971983 | Lesh | Oct 1999 | A |
5980516 | Mulier et al. | Nov 1999 | A |
5989248 | Tu et al. | Nov 1999 | A |
5993412 | Deily et al. | Nov 1999 | A |
5993447 | Blewett et al. | Nov 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6004316 | Laufer | Dec 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6010500 | Sherman et al. | Jan 2000 | A |
6012457 | Lesh | Jan 2000 | A |
6015391 | Rishton et al. | Jan 2000 | A |
6016811 | Knopp et al. | Jan 2000 | A |
6018676 | Davis et al. | Jan 2000 | A |
6019757 | Scheldrup | Feb 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6030381 | Jones et al. | Feb 2000 | A |
6036687 | Laufer et al. | Mar 2000 | A |
6042556 | Beach et al. | Mar 2000 | A |
6048333 | Lennox et al. | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6056745 | Panescu et al. | May 2000 | A |
6056746 | Goble | May 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6063081 | Mulier | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068653 | LaFontaine | May 2000 | A |
6071279 | Whayne et al. | Jun 2000 | A |
6083237 | Huitema et al. | Jul 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6088894 | Oakley | Jul 2000 | A |
6091995 | Ingle et al. | Jul 2000 | A |
6096037 | Mulier | Aug 2000 | A |
6113592 | Taylor | Sep 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6120496 | Whayne et al. | Sep 2000 | A |
6141576 | Littmann et al. | Oct 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6142994 | Swanson et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6149646 | West et al. | Nov 2000 | A |
6152920 | Thompson et al. | Nov 2000 | A |
6161543 | Cox et al. | Dec 2000 | A |
6165174 | Jacobs et al. | Dec 2000 | A |
6190384 | Ouchi | Feb 2001 | B1 |
6193716 | Shannon, Jr. | Feb 2001 | B1 |
6210406 | Webster | Apr 2001 | B1 |
6210410 | Farin et al. | Apr 2001 | B1 |
6210411 | Hofmann et al. | Apr 2001 | B1 |
6212426 | Swanson | Apr 2001 | B1 |
6216704 | Ingle et al. | Apr 2001 | B1 |
6217528 | Koblish et al. | Apr 2001 | B1 |
6217576 | Tu et al. | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6231518 | Grabek et al. | May 2001 | B1 |
6231591 | Desai | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6235024 | Tu | May 2001 | B1 |
6237605 | Vaska et al. | May 2001 | B1 |
6238347 | Nix et al. | May 2001 | B1 |
6238387 | Miller, III | May 2001 | B1 |
6238393 | Mulier | May 2001 | B1 |
6245061 | Panescu et al. | Jun 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6245065 | Panescu et al. | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6251128 | Knopp et al. | Jun 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6266551 | Osadchy et al. | Jul 2001 | B1 |
6270471 | Hechel et al. | Aug 2001 | B1 |
6283988 | Laufer et al. | Sep 2001 | B1 |
6283989 | Laufer et al. | Sep 2001 | B1 |
6293943 | Panescu et al. | Sep 2001 | B1 |
6296619 | Brisken et al. | Oct 2001 | B1 |
6299633 | Laufer | Oct 2001 | B1 |
6302880 | Schaer | Oct 2001 | B1 |
6311692 | Vaska et al. | Nov 2001 | B1 |
6312383 | Lizzi et al. | Nov 2001 | B1 |
6314962 | Vaska et al. | Nov 2001 | B1 |
6314963 | Vaska et al. | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6325797 | Stewart et al. | Dec 2001 | B1 |
6328735 | Curley et al. | Dec 2001 | B1 |
6328736 | Mulier | Dec 2001 | B1 |
6332881 | Carner et al. | Dec 2001 | B1 |
6352533 | Ellman et al. | Mar 2002 | B1 |
6358248 | Mulier | Mar 2002 | B1 |
6361531 | Hissong | Mar 2002 | B1 |
6364876 | Erb et al. | Apr 2002 | B1 |
6368275 | Sliwa et al. | Apr 2002 | B1 |
6371955 | Fuimaono et al. | Apr 2002 | B1 |
6371956 | Wilson et al. | Apr 2002 | B1 |
6383151 | Diederich et al. | May 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6409722 | Hoey | Jun 2002 | B1 |
6413254 | Hissong et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6419648 | Vitek et al. | Jul 2002 | B1 |
6425867 | Vaezy et al. | Jul 2002 | B1 |
6430426 | Avitall | Aug 2002 | B2 |
6440130 | Mulier | Aug 2002 | B1 |
6443952 | Mulier | Sep 2002 | B1 |
6447507 | Bednarek et al. | Sep 2002 | B1 |
6461314 | Pant et al. | Oct 2002 | B1 |
6461356 | Patterson | Oct 2002 | B1 |
6464700 | Koblish et al. | Oct 2002 | B1 |
6471697 | Lesh | Oct 2002 | B1 |
6471698 | Edwards et al. | Oct 2002 | B1 |
6474340 | Vaska et al. | Nov 2002 | B1 |
6475216 | Mulier et al. | Nov 2002 | B2 |
6477396 | Mest et al. | Nov 2002 | B1 |
6478793 | Cosman et al. | Nov 2002 | B1 |
6484727 | Vaska et al. | Nov 2002 | B1 |
6488678 | Sherman | Dec 2002 | B2 |
6488680 | Francischelli | Dec 2002 | B1 |
6497704 | Ein-Gal | Dec 2002 | B2 |
6502575 | Jacobs et al. | Jan 2003 | B1 |
6508815 | Strul et al. | Jan 2003 | B1 |
6514250 | Jahns | Feb 2003 | B1 |
6517536 | Hooven et al. | Feb 2003 | B2 |
6527767 | Wang et al. | Mar 2003 | B2 |
6537248 | Mulier | Mar 2003 | B2 |
6558382 | Jahns | May 2003 | B2 |
6558385 | McClurken et al. | May 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6579288 | Swanson et al. | Jun 2003 | B1 |
6584360 | Francischelli | Jun 2003 | B2 |
6585732 | Mulier | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6603988 | Dowlatshahi | Aug 2003 | B2 |
6605084 | Acker et al. | Aug 2003 | B2 |
6610055 | Swanson et al. | Aug 2003 | B1 |
6610060 | Mulier | Aug 2003 | B2 |
6613048 | Mulier | Sep 2003 | B2 |
6635034 | Cosmescu | Oct 2003 | B1 |
6645199 | Jenkins et al. | Nov 2003 | B1 |
6645202 | Pless et al. | Nov 2003 | B1 |
6648883 | Francischelli | Nov 2003 | B2 |
6656174 | Hegde et al. | Dec 2003 | B1 |
6656175 | Francischelli | Dec 2003 | B2 |
6663627 | Francischelli | Dec 2003 | B2 |
6666862 | Jain et al. | Dec 2003 | B2 |
6679882 | Kornerup | Jan 2004 | B1 |
6682501 | Nelson | Jan 2004 | B1 |
6689131 | McClurken | Feb 2004 | B2 |
6692450 | Coleman | Feb 2004 | B1 |
6699240 | Francischelli | Mar 2004 | B2 |
6702810 | McClurken et al. | Mar 2004 | B2 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6706038 | Francischelli | Mar 2004 | B2 |
6706039 | Mulier | Mar 2004 | B2 |
6716211 | Mulier | Apr 2004 | B2 |
6736810 | Hoey | May 2004 | B2 |
6755827 | Mulier | Jun 2004 | B2 |
6764487 | Mulier | Jul 2004 | B2 |
6766202 | Underwood et al. | Jul 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6773433 | Stewart et al. | Aug 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6776780 | Mulier | Aug 2004 | B2 |
6786906 | Cobb | Sep 2004 | B1 |
6807968 | Francischelli | Oct 2004 | B2 |
6827713 | Bek et al. | Dec 2004 | B2 |
6827715 | Francischelli | Dec 2004 | B2 |
6832996 | Woloszko et al. | Dec 2004 | B2 |
6849073 | Hoey | Feb 2005 | B2 |
6858028 | Mulier | Feb 2005 | B2 |
6887238 | Jahns | May 2005 | B2 |
6899711 | Stewart et al. | May 2005 | B2 |
6911019 | Mulier | Jun 2005 | B2 |
6915806 | Pacek et al. | Jul 2005 | B2 |
6916318 | Francischelli | Jul 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
6936046 | Hissong | Aug 2005 | B2 |
6942661 | Swanson | Sep 2005 | B2 |
6949097 | Stewart et al. | Sep 2005 | B2 |
6949098 | Mulier | Sep 2005 | B2 |
6953461 | McClurken et al. | Oct 2005 | B2 |
6960205 | Jahns | Nov 2005 | B2 |
6962589 | Mulier | Nov 2005 | B2 |
7066586 | da Silva | Jun 2006 | B2 |
7104990 | Jenkins et al. | Sep 2006 | B2 |
7156845 | Mulier et al. | Jan 2007 | B2 |
7166106 | Bartel et al. | Jan 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7252665 | Starkebaum et al. | Aug 2007 | B2 |
7261711 | Mulier et al. | Aug 2007 | B2 |
7309325 | Mulier et al. | Dec 2007 | B2 |
7311708 | McClurken | Dec 2007 | B2 |
7322974 | Swoyer et al. | Jan 2008 | B2 |
7361175 | Suslov | Apr 2008 | B2 |
7364579 | Mulier et al. | Apr 2008 | B2 |
7455669 | Swanson | Nov 2008 | B2 |
7537595 | McClurken | May 2009 | B2 |
7571729 | Saadat et al. | Aug 2009 | B2 |
7604635 | McClurken et al. | Oct 2009 | B2 |
7608072 | Swanson | Oct 2009 | B2 |
7645277 | McClurken et al. | Jan 2010 | B2 |
7651494 | McClurken et al. | Jan 2010 | B2 |
7691050 | Gellman et al. | Apr 2010 | B2 |
7736361 | Palanker | Jun 2010 | B2 |
7811282 | McClurken | Oct 2010 | B2 |
7815634 | McClurken et al. | Oct 2010 | B2 |
7819861 | Auge et al. | Oct 2010 | B2 |
7909820 | Lipson | Mar 2011 | B2 |
7942872 | Ein-Gal | May 2011 | B2 |
7976544 | McClurken et al. | Jul 2011 | B2 |
7993337 | Lesh | Aug 2011 | B2 |
7997278 | Utley et al. | Aug 2011 | B2 |
7998140 | McClurken et al. | Aug 2011 | B2 |
8034071 | Scribner et al. | Oct 2011 | B2 |
8038670 | McClurken | Oct 2011 | B2 |
8048070 | O'Brien et al. | Nov 2011 | B2 |
8083736 | McClurken et al. | Dec 2011 | B2 |
8105323 | Buysse et al. | Jan 2012 | B2 |
8172828 | Chang et al. | May 2012 | B2 |
8177783 | Davison et al. | May 2012 | B2 |
8216233 | McClurken | Jul 2012 | B2 |
8348946 | McClurken | Jan 2013 | B2 |
8361068 | McClurken | Jan 2013 | B2 |
8388642 | Muni et al. | Mar 2013 | B2 |
20020045892 | Kramer | Apr 2002 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020062131 | Gallo, Sr. | May 2002 | A1 |
20020082634 | Kammerer et al. | Jun 2002 | A1 |
20030014050 | Sharkey et al. | Jan 2003 | A1 |
20030032954 | Carranza et al. | Feb 2003 | A1 |
20030045872 | Jacobs | Mar 2003 | A1 |
20030073993 | Ciarrocca | Apr 2003 | A1 |
20030144656 | Ocel | Jul 2003 | A1 |
20030191462 | Jacobs | Oct 2003 | A1 |
20030204185 | Sherman et al. | Oct 2003 | A1 |
20030216724 | Jahns | Nov 2003 | A1 |
20040015106 | Coleman | Jan 2004 | A1 |
20040015219 | Francischelli | Jan 2004 | A1 |
20040024395 | Ellman et al. | Feb 2004 | A1 |
20040044340 | Francischelli | Mar 2004 | A1 |
20040049179 | Francischelli | Mar 2004 | A1 |
20040078069 | Francischelli | Apr 2004 | A1 |
20040082948 | Stewart et al. | Apr 2004 | A1 |
20040087940 | Jahns | May 2004 | A1 |
20040092926 | Hoey | May 2004 | A1 |
20040111136 | Sharkey et al. | Jun 2004 | A1 |
20040111137 | Sharkey et al. | Jun 2004 | A1 |
20040116923 | Desinger | Jun 2004 | A1 |
20040138621 | Jahns | Jul 2004 | A1 |
20040138656 | Francischelli | Jul 2004 | A1 |
20040143260 | Francischelli | Jul 2004 | A1 |
20040186465 | Francischelli | Sep 2004 | A1 |
20040215183 | Hoey | Oct 2004 | A1 |
20040220560 | Briscoe | Nov 2004 | A1 |
20040236322 | Mulier | Nov 2004 | A1 |
20040267326 | Ocel | Dec 2004 | A1 |
20050010095 | Stewart et al. | Jan 2005 | A1 |
20050033280 | Francischelli | Feb 2005 | A1 |
20050059966 | McClurken et al. | Mar 2005 | A1 |
20050090815 | Francischelli | Apr 2005 | A1 |
20050090816 | McClurken et al. | Apr 2005 | A1 |
20050143729 | Francischelli | Jun 2005 | A1 |
20050165392 | Francischelli | Jul 2005 | A1 |
20050171525 | Rioux | Aug 2005 | A1 |
20050209564 | Bonner | Sep 2005 | A1 |
20050267454 | Hissong | Dec 2005 | A1 |
20060009756 | Francischelli | Jan 2006 | A1 |
20060009759 | Christian | Jan 2006 | A1 |
20060064085 | Schechter et al. | Mar 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20070049920 | McClurken et al. | Mar 2007 | A1 |
20070093808 | Mulier et al. | Apr 2007 | A1 |
20070118114 | Miller et al. | May 2007 | A1 |
20070149965 | Gallo, Jr. et al. | Jun 2007 | A1 |
20070208332 | Mulier et al. | Sep 2007 | A1 |
20080004656 | Livneh | Jan 2008 | A1 |
20080015563 | Hoey et al. | Jan 2008 | A1 |
20080058796 | O'Brien et al. | Mar 2008 | A1 |
20080071270 | Desinger et al. | Mar 2008 | A1 |
20080103494 | Rioux | May 2008 | A1 |
20080207028 | Schutz | Aug 2008 | A1 |
20080221567 | Sixto et al. | Sep 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20090054892 | Rioux et al. | Feb 2009 | A1 |
20090177192 | Rioux et al. | Jul 2009 | A1 |
20090264879 | McClurken et al. | Oct 2009 | A1 |
20090270856 | Saadat et al. | Oct 2009 | A1 |
20090306655 | Stangenes et al. | Dec 2009 | A1 |
20100069904 | Cunningham | Mar 2010 | A1 |
20100100095 | McClurken et al. | Apr 2010 | A1 |
20100160906 | Jarrard | Jun 2010 | A1 |
20100168743 | Stone et al. | Jul 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20100241178 | Tilson et al. | Sep 2010 | A1 |
20100312259 | Houser et al. | Dec 2010 | A1 |
20100331883 | Schmitz et al. | Dec 2010 | A1 |
20110028965 | McClurken | Feb 2011 | A1 |
20110137298 | Nguyen et al. | Jun 2011 | A1 |
20110178515 | Bloom et al. | Jul 2011 | A1 |
20110196367 | Gallo | Aug 2011 | A1 |
20110295249 | Bloom et al. | Dec 2011 | A1 |
20110319889 | Conley et al. | Dec 2011 | A1 |
20120004657 | Conley et al. | Jan 2012 | A1 |
20120071712 | Manwaring et al. | Mar 2012 | A1 |
20120095461 | Herscher et al. | Apr 2012 | A1 |
20120101496 | Mcclurken et al. | Apr 2012 | A1 |
20120116397 | Rencher et al. | May 2012 | A1 |
20120143293 | Mauch et al. | Jun 2012 | A1 |
20120150165 | Conley et al. | Jun 2012 | A1 |
20120157989 | Stone et al. | Jun 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120191084 | Davison et al. | Jul 2012 | A1 |
20120253343 | McClurken et al. | Oct 2012 | A1 |
Number | Date | Country |
---|---|---|
WO9604955 | Feb 1996 | WO |
WO2010141417 | Dec 2010 | WO |
Entry |
---|
Salameh, F., et al., “An animal model study to clarify and investigate endoscopic tissue coagulation by using new monopolar device,” Gastrointestinal Endoscopy 59:107-112, American Society for Gastrointestinal Endoscopy (2004). |
Palanker, D. V., et al., “Electrosurgery with Cellular Precision,” IEEE Transactions on Biomedical Engineering 55:838-841, IEEE (2008). |
Barrx Brochure, “HALO Systems: Advanced Ablation Technology for Treating Barrett's Esophagus,” Barrx Medical Incorporated (2008), 8 pages. |
PCT International Search Report and Written Opinion dated Mar. 22, 2013. |
Number | Date | Country | |
---|---|---|---|
20130085493 A1 | Apr 2013 | US |